RSV Monovalent Antigen Investigational Vaccine
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for RSV Monovalent Antigen Investigational Vaccine, covering 2025-09-16 to 2025-09-16. Get the full timeline:
Most recent: Clinical Trial Update: Study to Evaluate the Safety and Immunogenicity of Investigational Vaccines Using the RSV (Respiratory Syncytial Virus) Monovalent Antigen in Healthy Participants 18 to 49 Years of Age [Phase 1]